Blood Viscosity in Polycythemia Patients
NCT06421025 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 160
Last updated 2025-11-21
Summary
Polycythemia (PG) corresponds to an increase in erythrocyte parameters on a blood test. A distinction is usually made between primary and secondary PG. The most common primary PG is Vaquez's disease, a hematological cancer. In Vaquez disease, an increase in hematocrit has been reported to be associated with a logarithmic increase in blood viscosity.
The main complications of primary PGs (especially in Vaquez disease) are thromboembolic complications. In contrast, thromboembolic complications are rarer in secondary PG. In Vaquez disease, a hematocrit ≤ 45% has been defined as the therapeutic goal for significantly reducing thromboembolic risk. However, this has not been established for secondary PGs. All in all, the definition of the 45% threshold is based solely on clinical studies with no obvious biological argument. What's more, simply lowering blood mass through cytoreduction alone does not appear to be sufficient to significantly reduce thromboembolic risk.
To investigator knowledge, there are no studies prospectively evaluating blood viscosity, its determinants and coagulation in different types of polycythemia. Nor are there any data on the direct effect on blood viscosity of the various treatments usually offered.
Conditions
- Polycythemia Secondary
- Polycythemia, Primary
Sponsors & Collaborators
-
Hospices Civils de Lyon
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-09-10
- Primary Completion
- 2031-09-10
- Completion
- 2031-09-10
Countries
- France
Study Locations
More Related Trials
-
An Observational Study of Early Coagulopathy, or Clotting Disorder, in Injured Patients
NCT00744003 ·Status: WITHDRAWN
-
Efficacy and Safety of Early Use PCC in Severe Trauma
NCT05738642 ·Status: COMPLETED ·Phase: NA
-
Coagulation Disorders Secondary to Two Plasmapheresis Techniques (Double Filtration Plasmapheresis vs. PFS). Descriptive Pilot Study.
NCT06571552 ·Status: RECRUITING ·Phase: NA
-
The Incidence of Early Trauma Induced Coagulopathy and Hyperfibrinolysis in Severely Injured Trauma Patients in the Emergency Room: a Retrospective Cohort Study
NCT07186712 ·Status: COMPLETED
-
Liberal Versus Restrictive Transfusion Threshold in Oncologic surgerY
NCT04506125 ·Status: COMPLETED ·Phase: NA
-
A Study on the Prevalence of Heparin-Induced Thrombocytopenia in Cardiovascular Patients
NCT00198575 ·Status: UNKNOWN
-
Transfusion Requirements in Surgical Oncologic Patient
NCT01502215 ·Status: COMPLETED ·Phase: PHASE3
-
Shock, Whole Blood, and Assessment of TBI S.W.A.T. (LITES TO 2)
NCT03402035 ·Status: COMPLETED
-
Transfusion Using Stored Whole Blood
NCT02926274 ·Status: COMPLETED
-
Hyperfibrinogenemia After Major Trauma
NCT02509390 ·Status: UNKNOWN ·Phase: NA
-
Coagulopathy in Acute Aortic Syndrome
NCT05149261 ·Status: UNKNOWN
-
Impact of RBC Transfusion Less Than 14 Days on Morbidity and Mortality in Cardiac Surgical Patients
NCT01915654 ·Status: TERMINATED
-
Prediction of Massive Transfusion in Trauma Patients
NCT04561050 ·Status: COMPLETED
-
Evaluating of the Hospital Universitario de Canarias Massive Transfusion Protocol
NCT03074890 ·Status: UNKNOWN ·Phase: NA
-
Whole Blood in Trauma Patients With Hemorrhagic Shock
NCT05634109 ·Status: RECRUITING ·Phase: PHASE3
-
Perioperative Hemostasis Management in Liver Transplantation
NCT06257407 ·Status: RECRUITING
-
Recurrence of Hereditary Hemorrhagic Telangiectasia (HHT) After Liver Transplantation
NCT03942315 ·Status: COMPLETED
-
AutoTransfusion Versus TRAnsfusion in Cancer Surgery
NCT05452538 ·Status: COMPLETED
-
Can Thrombelastography Predict Blood Loss in Patients With Hip Fractures
NCT02297061 ·Status: COMPLETED
-
Alterations in Coagulation Factor Levels in Patients With End Stage Liver Disease
NCT06014320 ·Status: UNKNOWN
-
Investigation of Coagulation Parameters in Hereditary Haemorrhagic Telangiectasia
NCT00230659 ·Status: COMPLETED
-
A Prospective Evaluation of Thromboelastography for Identifying Coagulopathy in Severely Injured Patients
NCT01228058 ·Status: COMPLETED
-
Platelet Transfusion in Critically Ill Patients With Thrombocytopenia
NCT06599385 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Hemostasis Profile in Patients With Severe Subarachnoid Hemorrhage
NCT03745456 ·Status: UNKNOWN
-
Platelet Activity in Vascular Surgery and Cardiovascular Events
NCT02106429 ·Status: COMPLETED